Technical Analysis for GOSS - Gossamer Bio, Inc.

Grade Last Price % Change Price Change
grade B 20.98 -5.15% -1.14
GOSS closed down 5.15 percent on Wednesday, June 26, 2019, on approximately normal volume.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Down
See historical GOSS trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
Upper Bollinger Band Walk Strength -5.15%
Wide Bands Range Expansion -5.15%
Overbought Stochastic Strength -5.15%
Upper Bollinger Band Walk Strength -5.32%
Wide Bands Range Expansion -5.32%
Overbought Stochastic Strength -5.32%
Upper Bollinger Band Touch Strength -5.32%

Older signals for GOSS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:
Profile
Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.
Biopharmaceutical Life Sciences Disease Inflammation Millennium Pharmaceuticals Takeda Pharmaceutical Company
Is GOSS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jun 7 Seth Klarman's Favorite Biotech Positions
Jun 5 AnaptysBio up 2% on positive etokimab data in severe asthma
May 16 Seth Klarman Introduces 7 New Positions in 1st Quarter
May 14 Gossamer Bio, Inc. (GOSS) CEO Sheila Gujrathi on Q1 2019 Results - Earnings Call Transcript
May 14 Gossamer Bio, Inc. (GOSS) Q1 2019 Earnings Call Transcript
May 14 Gossamer Bio: 1Q Earnings Snapshot
May 14 Gossamer Bio misses by $0.24
May 14 Gossamer Bio Announces First Quarter 2019 Financial Results
May 10 How Much Of Gossamer Bio, Inc. (NASDAQ:GOSS) Do Insiders Own?
May 9 Gossamer Bio to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 14, 2019
See more GOSS news...
Indicators
Indicator Value
52 Week High 25.06
52 Week Low 15.59
Average Volume 139,031
200-Day Moving Average 0.0
50-Day Moving Average 19.0986
20-Day Moving Average 20.01
10-Day Moving Average 21.442
Average True Range 1.3151
ADX 23.71
+DI 24.0914
-DI 16.5258
Chandelier Exit (Long, 3 ATRs ) 19.2247
Chandelier Exit (Short, 3 ATRs ) 20.9353
Upper Bollinger Band 23.317
Lower Bollinger Band 16.703
Percent B (%b) 0.65
BandWidth 33.053473
MACD Line 0.7682
MACD Signal Line 0.5839
MACD Histogram 0.1843
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.88
Resistance 3 (R3) 24.13 23.43 23.39
Resistance 2 (R2) 23.43 22.69 23.30 23.23
Resistance 1 (R1) 22.20 22.23 21.85 21.95 23.07
Pivot Point 21.50 21.50 21.32 21.37 21.50
Support 1 (S1) 20.27 20.76 19.92 20.02 18.89
Support 2 (S2) 19.57 20.30 19.44 18.73
Support 3 (S3) 18.34 19.57 18.57
Support 4 (S4) 18.09